Accuray, Inc. (ARAY)
1.10
+0.02
(+1.85%)
USD |
NASDAQ |
Dec 11, 16:00
1.09
-0.01
(-0.91%)
After-Hours: 20:00
Accuray Research and Development Expense (Quarterly): 11.27M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Becton, Dickinson & Co. | 322.00M |
| West Pharmaceutical Services, Inc. | 17.10M |
| Perspective Therapeutics, Inc. | 19.56M |
| Xtant Medical Holdings, Inc. | 0.634M |
| VolitionRX Ltd. | 2.022M |